Penumbra (PEN) Stock Forecast, Price Target & Predictions
PEN Stock Forecast
Penumbra stock forecast is as follows: an average price target of $218.89 (represents a 17.09% upside from PEN’s last price of $186.94) and a rating consensus of 'Hold', based on 13 wall street analysts offering a 1-year stock forecast.
PEN Price Target
PEN Analyst Ratings
Penumbra Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Sep 03, 2024 | Mike Kratky | Leerink Partners | $263.00 | $202.32 | 29.99% | 40.69% |
Jul 31, 2024 | Richard Newitter | Truist Financial | $200.00 | $173.09 | 15.55% | 6.99% |
Jul 31, 2024 | Larry Biegelsen | Wells Fargo | $150.00 | $173.09 | -13.34% | -19.76% |
Jul 31, 2024 | Matt O'Brien | Piper Sandler | $200.00 | $173.09 | 15.55% | 6.99% |
Jul 31, 2024 | Ryan Zimmerman | BTIG | $187.00 | $173.09 | 8.04% | 0.03% |
Jul 31, 2024 | Joanna Wuensch | Citigroup | $178.00 | $173.09 | 2.84% | -4.78% |
Jul 15, 2024 | Kallum Titchmarsh | Morgan Stanley | $210.00 | $190.83 | 10.05% | 12.34% |
Jul 15, 2024 | Ryan Zimmerman | BTIG | $232.00 | $190.83 | 21.57% | 24.10% |
Aug 02, 2023 | Richard Newitter | Truist Financial | $345.00 | $271.56 | 27.04% | 84.55% |
Feb 07, 2023 | - | Deutsche Bank | $297.00 | $267.10 | 11.19% | 58.87% |
Penumbra Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 1 | 8 | 8 |
Avg Price Target | $263.00 | $202.50 | $202.50 |
Last Closing Price | $186.94 | $186.94 | $186.94 |
Upside/Downside | 40.69% | 8.32% | 8.32% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 28, 2024 | BTIG | Buy | Buy | Hold |
Aug 22, 2024 | Citigroup | Neutral | Neutral | Hold |
Jul 31, 2024 | Wells Fargo | - | Equal-Weight | Downgrade |
Jul 31, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Jul 31, 2024 | Citigroup | Buy | Neutral | Downgrade |
Jul 15, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Jul 15, 2024 | BTIG | Buy | Buy | Hold |
Apr 15, 2024 | BTIG | Buy | Buy | Hold |
Mar 22, 2024 | Truist Financial | Buy | Buy | Hold |
Oct 02, 2023 | Citigroup | Buy | Buy | Hold |
Penumbra Financial Forecast
Penumbra Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $270.95M | $261.50M | $241.40M | $221.22M | $213.68M | $208.34M | $203.90M | $204.01M | $190.12M | $184.26M | $169.20M | $166.90M | $151.08M | $105.11M | $137.33M | $145.26M | $139.50M |
Avg Forecast | $430.83M | $408.82M | $409.64M | $383.22M | $362.72M | $344.22M | $339.03M | $318.13M | $312.58M | $297.45M | $298.24M | $275.20M | $286.62M | $265.38M | $253.59M | $229.68M | $217.33M | $212.49M | $206.24M | $195.39M | $194.29M | $181.06M | $170.77M | $152.64M | $155.40M | $124.95M | $100.74M | $136.28M | $141.40M | $133.98M |
High Forecast | $438.10M | $415.72M | $416.55M | $389.68M | $368.85M | $350.03M | $344.75M | $323.50M | $317.85M | $301.69M | $303.28M | $279.85M | $289.63M | $267.32M | $257.87M | $233.56M | $221.00M | $216.08M | $209.61M | $198.58M | $197.47M | $184.01M | $173.57M | $155.14M | $157.94M | $126.99M | $102.39M | $138.51M | $143.71M | $136.17M |
Low Forecast | $427.08M | $405.26M | $406.07M | $379.88M | $359.57M | $341.22M | $336.08M | $315.36M | $309.86M | $294.98M | $295.65M | $272.81M | $283.25M | $264.12M | $251.38M | $227.68M | $215.44M | $210.64M | $204.64M | $193.88M | $192.79M | $179.65M | $169.45M | $151.46M | $154.20M | $123.98M | $99.96M | $135.23M | $140.30M | $132.94M |
# Analysts | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.03% | 1.05% | 1.02% | 1.01% | 1.01% | 1.04% | 1.05% | 1.05% | 1.08% | 1.11% | 1.07% | 1.21% | 1.04% | 1.01% | 1.03% | 1.04% |
Penumbra EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $12.63M | $17.89M | $8.01M | $4.83M | $11.66M | $5.79M | $1.68M | $-35.20M | $12.23M | $14.69M | $16.85M | $3.96M | $-15.33M | $-12.96M | $2.75M | $14.45M | $15.50M |
Avg Forecast | $11.57M | $10.98M | $11.00M | $10.29M | $9.74M | $9.25M | $9.11M | $8.54M | $8.40M | $7.99M | $8.01M | $980.22K | $7.70M | $7.13M | $6.81M | $1.05M | $5.84M | $15.38M | $5.54M | $1.12M | $5.22M | $4.86M | $4.59M | $16.85M | $4.17M | $3.36M | $2.71M | $4.18M | $3.80M | $3.60M |
High Forecast | $11.77M | $11.17M | $11.19M | $10.47M | $9.91M | $9.40M | $9.26M | $8.69M | $8.54M | $8.10M | $8.15M | $1.18M | $7.78M | $7.18M | $6.93M | $1.26M | $5.94M | $18.46M | $5.63M | $1.35M | $5.30M | $4.94M | $4.66M | $20.22M | $4.24M | $3.41M | $2.75M | $5.01M | $3.86M | $3.66M |
Low Forecast | $11.47M | $10.88M | $10.91M | $10.20M | $9.66M | $9.16M | $9.03M | $8.47M | $8.32M | $7.92M | $7.94M | $784.18K | $7.61M | $7.09M | $6.75M | $838.70K | $5.79M | $12.30M | $5.50M | $897.00K | $5.18M | $4.83M | $4.55M | $13.48M | $4.14M | $3.33M | $2.68M | $3.34M | $3.77M | $3.57M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.77% | 2.63% | 7.64% | 0.83% | 0.76% | 1.05% | 1.50% | -6.75% | 2.52% | 3.20% | 1.00% | 0.95% | -4.57% | -4.79% | 0.66% | 3.81% | 4.31% |
Penumbra Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $9.21M | $18.96M | $8.56M | $3.88M | $-2.27M | $-3.69M | $79.00K | $-24.63M | $8.85M | $9.23M | $11.84M | $3.65M | $-8.81M | $-11.96M | $1.43M | $9.69M | $11.48M |
Avg Forecast | $53.83M | $42.97M | $38.25M | $31.57M | $43.22M | $37.08M | $34.07M | $26.93M | $33.85M | $27.70M | $21.56M | $134.67K | $27.11M | $17.63M | $10.85M | $144.04K | $5.67M | $11.13M | $-1.21M | $154.05K | $6.85M | $6.28M | $6.38M | $11.84M | $3.36M | $-3.77M | $-16.80M | $2.16M | $7.45M | $6.55M |
High Forecast | $55.01M | $43.91M | $39.09M | $32.26M | $44.17M | $37.89M | $34.82M | $27.52M | $34.59M | $33.16M | $22.03M | $161.61K | $33.22M | $20.76M | $11.09M | $172.84K | $5.80M | $13.35M | $-1.20M | $184.86K | $7.00M | $6.41M | $6.52M | $14.20M | $3.43M | $-3.73M | $-16.63M | $2.60M | $7.61M | $6.69M |
Low Forecast | $53.22M | $42.48M | $37.82M | $31.21M | $42.73M | $36.66M | $33.69M | $26.62M | $33.47M | $25.36M | $21.31M | $107.74K | $22.15M | $15.67M | $10.73M | $115.23K | $5.61M | $8.90M | $-1.24M | $123.24K | $6.78M | $6.21M | $6.32M | $9.47M | $3.32M | $-3.85M | $-17.16M | $1.73M | $7.37M | $6.49M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.52% | 1.75% | 59.44% | 0.68% | -0.20% | 3.04% | 0.51% | -3.60% | 1.41% | 1.45% | 1.00% | 1.09% | 2.34% | 0.71% | 0.66% | 1.30% | 1.75% |
Penumbra SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $125.92M | $127.44M | $123.08M | $115.63M | $108.57M | $114.61M | $110.90M | $113.50M | $94.40M | $90.64M | $79.80M | $76.60M | $76.16M | $59.85M | $74.45M | $74.69M | $69.29M |
Avg Forecast | $217.64M | $206.53M | $206.94M | $193.59M | $183.24M | $173.89M | $171.27M | $160.71M | $157.91M | $150.26M | $150.66M | $189.06M | $144.79M | $134.06M | $128.11M | $202.20M | $109.79M | $118.67M | $104.19M | $98.71M | $98.15M | $91.46M | $86.27M | $79.80M | $78.51M | $63.12M | $50.89M | $113.06M | $71.43M | $67.68M |
High Forecast | $221.32M | $210.01M | $210.43M | $196.86M | $186.33M | $176.82M | $174.16M | $163.42M | $160.57M | $152.41M | $153.21M | $226.87M | $146.31M | $135.04M | $130.27M | $242.64M | $111.64M | $142.40M | $105.89M | $100.32M | $99.76M | $92.96M | $87.68M | $95.76M | $79.79M | $64.15M | $51.73M | $135.67M | $72.60M | $68.79M |
Low Forecast | $215.75M | $204.73M | $205.14M | $191.91M | $181.64M | $172.38M | $169.78M | $159.31M | $156.53M | $149.02M | $149.35M | $151.24M | $143.09M | $133.42M | $126.99M | $161.76M | $108.83M | $94.94M | $103.38M | $97.94M | $97.39M | $90.76M | $85.60M | $63.84M | $77.90M | $62.63M | $50.50M | $90.44M | $70.88M | $67.16M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 0.99% | 0.61% | 1.05% | 0.91% | 1.10% | 1.12% | 1.16% | 1.03% | 1.05% | 1.00% | 0.98% | 1.21% | 1.18% | 0.66% | 1.05% | 1.02% |
Penumbra EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 9 | 9 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 12 | 6 | 4 | 7 | 12 | 9 | 9 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 9 | 15 | 9 | 9 | 8 | 8 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.24 | $0.49 | $0.22 | $0.10 | $-0.06 | $-0.10 | - | $-0.66 | $0.24 | $0.25 | $0.32 | $0.10 | $-0.24 | $-0.34 | $0.04 | $0.28 | $0.33 |
Avg Forecast | $1.39 | $1.11 | $0.99 | $0.81 | $1.11 | $0.96 | $0.88 | $0.69 | $0.87 | $0.71 | $0.56 | $0.39 | $0.70 | $0.45 | $0.28 | $0.11 | $0.15 | $-0.00 | $-0.03 | $0.04 | $0.18 | $0.16 | $0.16 | $0.09 | $0.09 | $-0.10 | $-0.43 | $0.13 | $0.19 | $0.17 |
High Forecast | $1.42 | $1.13 | $1.01 | $0.83 | $1.14 | $0.98 | $0.90 | $0.71 | $0.89 | $0.85 | $0.57 | $0.39 | $0.86 | $0.54 | $0.29 | $0.11 | $0.15 | $-0.00 | $-0.03 | $0.04 | $0.18 | $0.17 | $0.17 | $0.09 | $0.09 | $-0.10 | $-0.43 | $0.13 | $0.20 | $0.17 |
Low Forecast | $1.37 | $1.10 | $0.97 | $0.80 | $1.10 | $0.94 | $0.87 | $0.69 | $0.86 | $0.65 | $0.55 | $0.38 | $0.57 | $0.40 | $0.28 | $0.11 | $0.14 | $-0.00 | $-0.03 | $0.04 | $0.17 | $0.16 | $0.16 | $0.09 | $0.09 | $-0.10 | $-0.44 | $0.13 | $0.19 | $0.17 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.53% | 1.75% | 2.02% | 0.68% | 15.58% | 3.12% | 0.05% | -3.74% | 1.48% | 1.52% | 3.56% | 1.16% | 2.47% | 0.79% | 0.30% | 1.46% | 1.95% |
Penumbra Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
TNDM | Tandem Diabetes Care | $43.97 | $84.44 | 92.04% | Buy |
IRTC | iRhythm | $76.61 | $144.20 | 88.23% | Buy |
INMD | InMode | $17.04 | $31.40 | 84.27% | Hold |
NARI | Inari Medical | $46.52 | $72.88 | 56.66% | Buy |
LIVN | LivaNova | $48.53 | $71.25 | 46.82% | Buy |
MASI | Masimo | $112.80 | $158.40 | 40.43% | Buy |
CNMD | CONMED | $75.40 | $101.00 | 33.95% | Buy |
DXCM | DexCom | $69.51 | $81.86 | 17.77% | Buy |
PEN | Penumbra | $186.94 | $218.89 | 17.09% | Hold |
INSP | Inspire Medical Systems | $203.99 | $237.80 | 16.57% | Buy |
PODD | Insulet | $233.87 | $268.60 | 14.85% | Buy |
TMDX | TransMedics Group | $151.42 | $156.86 | 3.59% | Buy |
ITGR | Integer | $126.78 | $131.00 | 3.33% | Buy |
SWAV | ShockWave Medical | $334.75 | $258.17 | -22.88% | Hold |
PEN Forecast FAQ
Is Penumbra a good buy?
No, according to 13 Wall Street analysts, Penumbra (PEN) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 46.15% of PEN's total ratings.
What is PEN's price target?
Penumbra (PEN) average price target is $218.89 with a range of $150 to $297, implying a 17.09% from its last price of $186.94. The data is based on 13 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Penumbra stock go up soon?
According to Wall Street analysts' prediction for PEN stock, the company can go up by 17.09% (from the last price of $186.94 to the average price target of $218.89), up by 58.87% based on the highest stock price target, and down by -19.76% based on the lowest stock price target.
Can Penumbra stock reach $300?
PEN's average twelve months analyst stock price target of $218.89 does not support the claim that Penumbra can reach $300 in the near future.
What is Penumbra's current price target trend?
1 Wall Street analyst forecast a $263 price target for Penumbra (PEN) this month, up 40.69% from its last price of $186.94. Compared to the last 3 and 12 months, the average price target increased by 8.32% and increased by 8.32%, respectively.
What are Penumbra's analysts' financial forecasts?
Penumbra's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.36B (high $1.39B, low $1.35B), average EBITDA is $36.64M (high $37.26M, low $36.32M), average net income is $141.3M (high $144.4M, low $139.7M), average SG&A $689.11M (high $700.73M, low $683.11M), and average EPS is $3.64 (high $3.72, low $3.6). PEN's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.63B (high $1.66B, low $1.62B), average EBITDA is $43.85M (high $44.59M, low $43.47M), average net income is $166.62M (high $170.28M, low $164.74M), average SG&A $824.7M (high $838.62M, low $817.52M), and average EPS is $4.3 (high $4.39, low $4.25).
Did the PEN's actual financial results beat the analysts' financial forecasts?
Based on Penumbra's last annual report (Dec 2022), the company's revenue was $847.13M, beating the average analysts forecast of $831.45M by 1.89%. Apple's EBITDA was $6.08M, missing the average prediction of $27.88M by -78.18%. The company's net income was $-2.002M, missing the average estimation of $15.74M by -112.72%. Apple's SG&A was $449.72M, beating the average forecast of $431.35M by 4.26%. Lastly, the company's EPS was $-0.0529, missing the average prediction of $0.151 by -134.94%. In terms of the last quarterly report (Sep 2023), Penumbra's revenue was $270.95M, beating the average analysts' forecast of $265.38M by 2.10%. The company's EBITDA was $12.62M, beating the average prediction of $7.13M by 77.13%. Penumbra's net income was $9.21M, missing the average estimation of $17.63M by -47.72%. The company's SG&A was $125.92M, missing the average forecast of $134.06M by -6.07%. Lastly, the company's EPS was $0.24, missing the average prediction of $0.454 by -47.18%